in the intention-to-treat population (difference, −4.3 percentage
points [95% CI, −13.5 to 4.8]). Our study was
not powered to determine the superiority of one
agent over the other in the subgroup of patients
with cellulitis, but the data suggest that if there
is a difference in outcome it is probably small.